Pre-order Enquiry
Request Free Sample
Global Inactivated Poliovirus Vaccine Market Research Report 2020
SKU ID : QYR-15428094 | Publishing Date : 06-Mar-2020 | No. of pages : 95
Detailed TOC of Global Inactivated Poliovirus Vaccine Market Research Report 2020
Table of Contents1 Inactivated Poliovirus Vaccine Market Overview
1.1 Product Overview and Scope of Inactivated Poliovirus Vaccine
1.2 Inactivated Poliovirus Vaccine Segment by Type
1.2.1 Global Inactivated Poliovirus Vaccine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Human Diploid Cell
1.2.3 Monkey Kidney Cell
1.3 Inactivated Poliovirus Vaccine Segment by Application
1.3.1 Inactivated Poliovirus Vaccine Sales Comparison by Application: 2020 VS 2026
1.3.2 Public
1.3.3 Private
1.4 Global Inactivated Poliovirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Inactivated Poliovirus Vaccine Revenue 2015-2026
1.4.2 Global Inactivated Poliovirus Vaccine Sales 2015-2026
1.4.3 Inactivated Poliovirus Vaccine Market Size by Region: 2020 Versus 2026
2 Global Inactivated Poliovirus Vaccine Market Competition by Manufacturers
2.1 Global Inactivated Poliovirus Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Inactivated Poliovirus Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global Inactivated Poliovirus Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Inactivated Poliovirus Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Inactivated Poliovirus Vaccine Market Competitive Situation and Trends
2.5.1 Inactivated Poliovirus Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Inactivated Poliovirus Vaccine Players (Opinion Leaders)
3 Inactivated Poliovirus Vaccine Retrospective Market Scenario by Region
3.1 Global Inactivated Poliovirus Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Inactivated Poliovirus Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Inactivated Poliovirus Vaccine Market Facts & Figures by Country
3.3.1 North America Inactivated Poliovirus Vaccine Sales by Country
3.3.2 North America Inactivated Poliovirus Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Inactivated Poliovirus Vaccine Market Facts & Figures by Country
3.4.1 Europe Inactivated Poliovirus Vaccine Sales by Country
3.4.2 Europe Inactivated Poliovirus Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Inactivated Poliovirus Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Inactivated Poliovirus Vaccine Sales by Region
3.5.2 Asia Pacific Inactivated Poliovirus Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Inactivated Poliovirus Vaccine Market Facts & Figures by Country
3.6.1 Latin America Inactivated Poliovirus Vaccine Sales by Country
3.6.2 Latin America Inactivated Poliovirus Vaccine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Inactivated Poliovirus Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Inactivated Poliovirus Vaccine Sales by Country
3.7.2 Middle East and Africa Inactivated Poliovirus Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Inactivated Poliovirus Vaccine Historic Market Analysis by Type
4.1 Global Inactivated Poliovirus Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Inactivated Poliovirus Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Inactivated Poliovirus Vaccine Price Market Share by Type (2015-2020)
4.4 Global Inactivated Poliovirus Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Inactivated Poliovirus Vaccine Historic Market Analysis by Application
5.1 Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Inactivated Poliovirus Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Inactivated Poliovirus Vaccine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Inactivated Poliovirus Vaccine Business
6.1 Sanofi
6.1.1 Corporation Information
6.1.2 Sanofi Description, Business Overview and Total Revenue
6.1.3 Sanofi Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Sanofi Products Offered
6.1.5 Sanofi Recent Development
6.2 GSK
6.2.1 GSK Inactivated Poliovirus Vaccine Production Sites and Area Served
6.2.2 GSK Description, Business Overview and Total Revenue
6.2.3 GSK Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 GSK Products Offered
6.2.5 GSK Recent Development
6.3 Serum Institute (Bilthoven Biologicals)
6.3.1 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Production Sites and Area Served
6.3.2 Serum Institute (Bilthoven Biologicals) Description, Business Overview and Total Revenue
6.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Serum Institute (Bilthoven Biologicals) Products Offered
6.3.5 Serum Institute (Bilthoven Biologicals) Recent Development
6.4 IMBCA
6.4.1 IMBCA Inactivated Poliovirus Vaccine Production Sites and Area Served
6.4.2 IMBCA Description, Business Overview and Total Revenue
6.4.3 IMBCA Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 IMBCA Products Offered
6.4.5 IMBCA Recent Development
7 Inactivated Poliovirus Vaccine Manufacturing Cost Analysis
7.1 Inactivated Poliovirus Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Inactivated Poliovirus Vaccine
7.4 Inactivated Poliovirus Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Inactivated Poliovirus Vaccine Distributors List
8.3 Inactivated Poliovirus Vaccine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Inactivated Poliovirus Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Inactivated Poliovirus Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Inactivated Poliovirus Vaccine by Type (2021-2026)
10.2 Inactivated Poliovirus Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Inactivated Poliovirus Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Inactivated Poliovirus Vaccine by Application (2021-2026)
10.3 Inactivated Poliovirus Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Inactivated Poliovirus Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Inactivated Poliovirus Vaccine by Region (2021-2026)
10.4 North America Inactivated Poliovirus Vaccine Estimates and Projections (2021-2026)
10.5 Europe Inactivated Poliovirus Vaccine Estimates and Projections (2021-2026)
10.6 Asia Pacific Inactivated Poliovirus Vaccine Estimates and Projections (2021-2026)
10.7 Latin America Inactivated Poliovirus Vaccine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Inactivated Poliovirus Vaccine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Inactivated Poliovirus Vaccine Market Research Report 2020
List of TablesTable 1. Global Inactivated Poliovirus Vaccine Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Inactivated Poliovirus Vaccine Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Inactivated Poliovirus Vaccine Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Inactivated Poliovirus Vaccine Manufacturers Covered in This Study
Table 5. Global Inactivated Poliovirus Vaccine Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Inactivated Poliovirus Vaccine Sales Share by Manufacturers (2015-2020)
Table 7. Global Inactivated Poliovirus Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Inactivated Poliovirus Vaccine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Inactivated Poliovirus Vaccine Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Inactivated Poliovirus Vaccine Sales Sites and Area Served
Table 11. Manufacturers Inactivated Poliovirus Vaccine Product Types
Table 12. Global Inactivated Poliovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Inactivated Poliovirus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inactivated Poliovirus Vaccine as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Inactivated Poliovirus Vaccine Players
Table 16. Global Inactivated Poliovirus Vaccine Sales (K Units) by Region (2015-2020)
Table 17. Global Inactivated Poliovirus Vaccine Sales Market Share by Region (2015-2020)
Table 18. Global Inactivated Poliovirus Vaccine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Inactivated Poliovirus Vaccine Revenue Market Share by Region (2015-2020)
Table 20. North America Inactivated Poliovirus Vaccine Sales by Country (2015-2020) (K Units)
Table 21. North America Inactivated Poliovirus Vaccine Sales Market Share by Country (2015-2020)
Table 22. North America Inactivated Poliovirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Inactivated Poliovirus Vaccine Revenue Market Share by Country (2015-2020)
Table 24. Europe Inactivated Poliovirus Vaccine Sales by Country (2015-2020) (K Units)
Table 25. Europe Inactivated Poliovirus Vaccine Sales Market Share by Country (2015-2020)
Table 26. Europe Inactivated Poliovirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Inactivated Poliovirus Vaccine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Inactivated Poliovirus Vaccine Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Inactivated Poliovirus Vaccine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Inactivated Poliovirus Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Inactivated Poliovirus Vaccine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Inactivated Poliovirus Vaccine Sales by Country (2015-2020) (K Units)
Table 33. Latin America Inactivated Poliovirus Vaccine Sales Market Share by Country (2015-2020)
Table 34. Latin America Inactivated Poliovirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Inactivated Poliovirus Vaccine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Inactivated Poliovirus Vaccine Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Inactivated Poliovirus Vaccine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Inactivated Poliovirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Inactivated Poliovirus Vaccine Revenue Market Share by Country (2015-2020)
Table 40. Global Inactivated Poliovirus Vaccine Sales (K Units) by Type (2015-2020)
Table 41. Global Inactivated Poliovirus Vaccine Sales Share by Type (2015-2020)
Table 42. Global Inactivated Poliovirus Vaccine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Inactivated Poliovirus Vaccine Revenue Share by Type (2015-2020)
Table 44. Global Inactivated Poliovirus Vaccine Price (USD/Unit) by Type (2015-2020)
Table 45. Global Inactivated Poliovirus Vaccine Sales (K Units) by Application (2015-2020)
Table 46. Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2015-2020)
Table 47. Global Inactivated Poliovirus Vaccine Sales Growth Rate by Application (2015-2020)
Table 48. Sanofi Inactivated Poliovirus Vaccine Corporation Information
Table 49. Sanofi Description and Business Overview
Table 50. Sanofi Inactivated Poliovirus Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Sanofi Main Product
Table 52. Sanofi Recent Development
Table 53. GSK Inactivated Poliovirus Vaccine Corporation Information
Table 54. GSK Corporation Information
Table 55. GSK Inactivated Poliovirus Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. GSK Main Product
Table 57. GSK Recent Development
Table 58. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Corporation Information
Table 59. Serum Institute (Bilthoven Biologicals) Corporation Information
Table 60. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Serum Institute (Bilthoven Biologicals) Main Product
Table 62. Serum Institute (Bilthoven Biologicals) Recent Development
Table 63. IMBCA Inactivated Poliovirus Vaccine Corporation Information
Table 64. IMBCA Corporation Information
Table 65. IMBCA Inactivated Poliovirus Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. IMBCA Main Product
Table 67. IMBCA Recent Development
Table 68. Sales Base and Market Concentration Rate of Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Inactivated Poliovirus Vaccine Distributors List
Table 71. Inactivated Poliovirus Vaccine Customers List
Table 72. Market Key Trends
Table 73. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 74. Key Challenges
Table 75. Global Inactivated Poliovirus Vaccine Sales (K Units) Forecast by Type (2021-2026)
Table 76. Global Inactivated Poliovirus Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 77. Global Inactivated Poliovirus Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 78. Global Inactivated Poliovirus Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 79. Global Inactivated Poliovirus Vaccine Sales (K Units) Forecast by Application (2021-2026)
Table 80. Global Inactivated Poliovirus Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
Table 81. Global Inactivated Poliovirus Vaccine Sales (K Units) Forecast by Region (2021-2026)
Table 82. Global Inactivated Poliovirus Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 83. Global Inactivated Poliovirus Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 84. Global Inactivated Poliovirus Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Inactivated Poliovirus Vaccine
Figure 2. Global Inactivated Poliovirus Vaccine Sales Market Share by Type: 2020 VS 2026
Figure 3. Human Diploid Cell Product Picture
Figure 4. Monkey Kidney Cell Product Picture
Figure 5. Global Inactivated Poliovirus Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 6. Public
Figure 7. Private
Figure 8. Global Inactivated Poliovirus Vaccine Market Size 2015-2026 (US$ Million)
Figure 9. Global Inactivated Poliovirus Vaccine Sales Capacity (K Units) (2015-2026)
Figure 10. Global Inactivated Poliovirus Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Inactivated Poliovirus Vaccine Sales Share by Manufacturers in 2020
Figure 12. Global Inactivated Poliovirus Vaccine Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Inactivated Poliovirus Vaccine Revenue in 2019
Figure 14. Inactivated Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Inactivated Poliovirus Vaccine Sales Market Share by Region (2015-2020)
Figure 16. Global Inactivated Poliovirus Vaccine Sales Market Share by Region in 2019
Figure 17. Global Inactivated Poliovirus Vaccine Revenue Market Share by Region (2015-2020)
Figure 18. Global Inactivated Poliovirus Vaccine Revenue Market Share by Region in 2019
Figure 19. North America Inactivated Poliovirus Vaccine Sales Market Share by Country in 2019
Figure 20. North America Inactivated Poliovirus Vaccine Revenue Market Share by Country in 2019
Figure 21. U.S. Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 22. U.S. Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 24. Canada Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe Inactivated Poliovirus Vaccine Sales Market Share by Country in 2019
Figure 26. Europe Inactivated Poliovirus Vaccine Revenue Market Share by Country in 2019
Figure 27. Germany Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 28. Germany Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 30. France Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 32. U.K. Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 36. Russia Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific Inactivated Poliovirus Vaccine Sales Market Share by Region in 2019
Figure 38. Asia Pacific Inactivated Poliovirus Vaccine Revenue Market Share by Region in 2019
Figure 39. China Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 40. China Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 42. Japan Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 44. South Korea Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 46. India Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 48. Australia Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 50. Taiwan Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 54. Thailand Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 56. Malaysia Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 58. Philippines Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 60. Vietnam Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America Inactivated Poliovirus Vaccine Sales Market Share by Country in 2019
Figure 62. Latin America Inactivated Poliovirus Vaccine Revenue Market Share by Country in 2019
Figure 63. Mexico Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 64. Mexico Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 66. Brazil Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 68. Argentina Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa Inactivated Poliovirus Vaccine Sales Market Share by Country in 2019
Figure 70. Middle East and Africa Inactivated Poliovirus Vaccine Revenue Market Share by Country in 2019
Figure 71. Turkey Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 72. Turkey Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Saudi Arabia Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. U.A.E Inactivated Poliovirus Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 76. U.A.E Inactivated Poliovirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of Inactivated Poliovirus Vaccine by Type (2015-2020)
Figure 78. Sales Market Share of Inactivated Poliovirus Vaccine by Type in 2019
Figure 79. Revenue Share of Inactivated Poliovirus Vaccine by Type (2015-2020)
Figure 80. Revenue Market Share of Inactivated Poliovirus Vaccine by Type in 2019
Figure 81. Global Inactivated Poliovirus Vaccine Sales Growth by Type (2015-2020) (K Units)
Figure 82. Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2015-2020)
Figure 83. Global Inactivated Poliovirus Vaccine Sales Market Share by Application in 2019
Figure 84. Global Revenue Share of Inactivated Poliovirus Vaccine by Application (2015-2020)
Figure 85. Global Revenue Share of Inactivated Poliovirus Vaccine by Application in 2020
Figure 86. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Serum Institute (Bilthoven Biologicals) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. IMBCA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Price Trend of Key Raw Materials
Figure 91. Manufacturing Cost Structure of Inactivated Poliovirus Vaccine
Figure 92. Manufacturing Process Analysis of Inactivated Poliovirus Vaccine
Figure 93. Inactivated Poliovirus Vaccine Industrial Chain Analysis
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Porter's Five Forces Analysis
Figure 97. North America Inactivated Poliovirus Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 98. North America Inactivated Poliovirus Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 99. Europe Inactivated Poliovirus Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 100. Europe Inactivated Poliovirus Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 101. Latin America Inactivated Poliovirus Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 102. Latin America Inactivated Poliovirus Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 103. Middle East and Africa Inactivated Poliovirus Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 104. Middle East and Africa Inactivated Poliovirus Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Asia Pacific Inactivated Poliovirus Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. Asia Pacific Inactivated Poliovirus Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed
Keyplayers in Global Inactivated Poliovirus Vaccine Market Research Report 2020
SanofiGSK
Serum Institute (Bilthoven Biologicals)
IMBCA
Request Sample
Request Discount
